Doege Daniela, Frick Julien, Eckford Rachel D, Koch-Gallenkamp Lena, Schlander Michael, Arndt Volker
Unit of Cancer Survivorship, Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Epidemiological Cancer Registry of Baden-Württemberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Int J Cancer. 2025 Feb 15;156(4):711-722. doi: 10.1002/ijc.35204. Epub 2024 Oct 3.
Treatment modifications and contact restrictions were common during the COVID-19 pandemic and can be stressors for mental health. There is a lack of studies assessing pandemic-related risk factors for anxiety and depression of cancer patients and survivors systematically in multifactorial models. A total of 2391 participants, mean age 65.5 years, ≤5 years post-diagnosis of either lung, prostate, breast, colorectal cancer, or leukemia/lymphoma, were recruited in 2021 via the Baden-Württemberg Cancer Registry, Germany. Sociodemographic information, pandemic-related treatment modifications, contact restrictions, and anxiety/depression (Hospital Anxiety and Depression Scale, HADS) were assessed via self-administered questionnaire. Clinical information (diagnosis, stage, and treatment information) was obtained from the cancer registry. Overall, 22% of participants reported oncological care modifications due to COVID-19, mostly in follow-up care and rehabilitation. Modifications of active cancer treatment were reported by 5.8%. Among those, 50.5% had subclinical anxiety and 55.4% subclinical depression (vs. 37.4% and 45.4%, respectively, for unchanged active treatment). Age <60 years, female sex, lung cancer, low income, and contact restrictions to peer support groups or physicians were identified as independent risk factors for anxiety. Risk factors for depression were lung cancer (both sexes), leukemia/lymphoma (females), recurrence or palliative treatment, living alone, low income, and contact restrictions to relatives, physicians, or caregivers. The study demonstrates that changes in active cancer treatment and contact restrictions are associated with impaired mental well-being. The psychological consequences of treatment changes and the importance for cancer patients to maintain regular contact with their physicians should be considered in future responses to threats to public health.
在新冠疫情期间,治疗调整和接触限制很常见,并且可能成为心理健康的压力源。目前缺乏在多因素模型中系统评估癌症患者及幸存者焦虑和抑郁的大流行相关风险因素的研究。2021年,通过德国巴登-符腾堡州癌症登记处招募了总共2391名参与者,平均年龄65.5岁,在诊断为肺癌、前列腺癌、乳腺癌、结直肠癌或白血病/淋巴瘤后≤5年。通过自行填写问卷评估社会人口统计学信息、与大流行相关的治疗调整、接触限制以及焦虑/抑郁情况(医院焦虑抑郁量表,HADS)。临床信息(诊断、分期和治疗信息)从癌症登记处获取。总体而言,22%的参与者报告因新冠疫情而有肿瘤护理调整,主要是在后续护理和康复方面。报告有积极癌症治疗调整的占5.8%。其中,50.5%有亚临床焦虑,55.4%有亚临床抑郁(而积极治疗未改变的分别为37.4%和45.4%)。年龄<60岁、女性、肺癌、低收入以及与同伴支持小组或医生的接触限制被确定为焦虑的独立风险因素。抑郁的风险因素包括肺癌(男女皆有)、白血病/淋巴瘤(女性)、复发或姑息治疗、独居、低收入以及与亲属、医生或护理人员的接触限制。该研究表明,积极癌症治疗的改变和接触限制与心理健康受损有关。在未来应对公共卫生威胁时,应考虑治疗改变的心理后果以及癌症患者与医生保持定期联系的重要性。